# Developing an intuitive decision support system for equitable vaccine distribution during pandemics

**Authors:** Lise Boey, Hossein Baharmand, Ross Owen Phillips, Nico Vandaele, Burcu Balcik, Jan Ove Kjøndal, Asle Birkeland, Håvard Fossli, Naima Saeed, Catherine Decouttere

PMC · DOI: 10.1038/s41598-025-01640-9 · Scientific Reports · 2025-05-10

## TL;DR

This paper introduces a decision support system to help health officials equitably distribute vaccines during pandemics by combining stakeholder input and user-centered design.

## Contribution

The novel approach integrates stakeholder knowledge and user-centered design to create a flexible and transparent vaccine allocation decision support system.

## Key findings

- A dashboard was developed to embed a mathematical model for equitable vaccine allocation.
- The system was validated with policymakers and adapted for the Norwegian context.
- The approach allows flexibility for use in regions with vaccine supply deficits.

## Abstract

Effective organization of the vaccine supply chain is vital to achieve high vaccination rates in pandemics. This paper presents a novel approach for developing a decision support system (DSS) to support health officials and policymakers who must make timely and impactful decisions with limited information for distributing vaccines. We combine a stakeholder-informed systems approach for problem definition with a user-centered design approach for DSS development. The methodology has been tested during the COVID-19 pandemic. We used system modeling to capture stakeholders’ knowledge, experience, and learnings from the H1N1 pandemic, leading us to focus on the central vaccine allocation problem (CVAP), which involves determining the number of vaccines allocated to each municipality in an equitable way. We designed a dashboard that embedded a mathematical model as a DSS for in-country CVAP during a pandemic. A Lightning Decision Jam workshop was conducted to define the DSS’s characteristics, with the visualization of scenarios and decision-making transparency being key features during the development process. We validated the DSS with policymakers and built it for the Norwegian context, with flexibility for adaptation to other regions, particularly those still grappling with high vaccine supply deficits. Our approach offers a novel and practical way to develop DSSs to support policymakers making critical decisions during pandemics.

The online version contains supplementary material available at 10.1038/s41598-025-01640-9.

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)
- **Species:** H1N1 subtype (serotype) [taxon 114727]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12065852/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12065852/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12065852/full.md

---
Source: https://tomesphere.com/paper/PMC12065852